Cargando…

Concerns about the inverse relationship between baseline HBV DNA and on-treatment hepatocellular carcinoma risk. Reply.

Detalles Bibliográficos
Autores principales: Choi, Won-Mook, Lim, Young-Suk
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Clinical Investigation 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9337818/
https://www.ncbi.nlm.nih.gov/pubmed/35912858
http://dx.doi.org/10.1172/JCI161425
_version_ 1784759837461053440
author Choi, Won-Mook
Lim, Young-Suk
author_facet Choi, Won-Mook
Lim, Young-Suk
author_sort Choi, Won-Mook
collection PubMed
description
format Online
Article
Text
id pubmed-9337818
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher American Society for Clinical Investigation
record_format MEDLINE/PubMed
spelling pubmed-93378182022-08-03 Concerns about the inverse relationship between baseline HBV DNA and on-treatment hepatocellular carcinoma risk. Reply. Choi, Won-Mook Lim, Young-Suk J Clin Invest Letter to the Editor American Society for Clinical Investigation 2022-08-01 2022-08-01 /pmc/articles/PMC9337818/ /pubmed/35912858 http://dx.doi.org/10.1172/JCI161425 Text en © 2022 Choi et al. https://creativecommons.org/licenses/by/4.0/This work is licensed under the Creative Commons Attribution 4.0 International License. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Letter to the Editor
Choi, Won-Mook
Lim, Young-Suk
Concerns about the inverse relationship between baseline HBV DNA and on-treatment hepatocellular carcinoma risk. Reply.
title Concerns about the inverse relationship between baseline HBV DNA and on-treatment hepatocellular carcinoma risk. Reply.
title_full Concerns about the inverse relationship between baseline HBV DNA and on-treatment hepatocellular carcinoma risk. Reply.
title_fullStr Concerns about the inverse relationship between baseline HBV DNA and on-treatment hepatocellular carcinoma risk. Reply.
title_full_unstemmed Concerns about the inverse relationship between baseline HBV DNA and on-treatment hepatocellular carcinoma risk. Reply.
title_short Concerns about the inverse relationship between baseline HBV DNA and on-treatment hepatocellular carcinoma risk. Reply.
title_sort concerns about the inverse relationship between baseline hbv dna and on-treatment hepatocellular carcinoma risk. reply.
topic Letter to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9337818/
https://www.ncbi.nlm.nih.gov/pubmed/35912858
http://dx.doi.org/10.1172/JCI161425
work_keys_str_mv AT choiwonmook concernsabouttheinverserelationshipbetweenbaselinehbvdnaandontreatmenthepatocellularcarcinomariskreply
AT limyoungsuk concernsabouttheinverserelationshipbetweenbaselinehbvdnaandontreatmenthepatocellularcarcinomariskreply